How estrogen affects binge drinking through serotonin neurons
Doral raphe 5-HT neurons mediating estrogenic regulation of binge drinking
This study is looking at how the hormone estrogen affects binge drinking, especially in women, by exploring its impact on certain brain cells that help control drinking behavior, with the hope of finding better treatments for alcohol use issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11091635 on NIH RePORTER |
What this research studies
This research investigates the relationship between the hormone estrogen and binge drinking behavior, particularly focusing on how estrogen influences serotonin neurons in the brain. The study aims to understand the mechanisms by which estrogen affects alcohol intake, especially in females, by examining specific receptors in serotonin neurons. Researchers will conduct experiments to determine the role of these receptors in regulating binge drinking and how they respond differently based on sex. The findings could provide insights into targeted treatments for alcohol use disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals who struggle with binge drinking or alcohol use disorders, especially women.
Not a fit: Patients who do not have issues with alcohol consumption or those who are not affected by hormonal changes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing and treating alcohol use disorders, particularly in women.
How similar studies have performed: Previous research has shown promising results in understanding the role of estrogen in alcohol consumption, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Xu, Pingwen — University of Illinois at Chicago
- Study coordinator: Xu, Pingwen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.